ODT renewal of o & m, DME and advisory support services

Ended Awarded Last action

Contract number
75F40123F19012
Awardee
Awarding agency
Obligated
$20,337,833

Award facts

Contract value 97% obligated
  • $20,337,832.82 Current, with exercised options
  • $20,920,983.52 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Labor Hours
Place of performance
Reston, VA 20190, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00009 · Exercise transition out option $110,528
Other Administrative Action P00008 $0
Terminate for Convenience P00007 · EOI:: HHS cost efficiency initiative:: EOI termination for convenience agreement -$290,780
Funding Only Action P00006 · MOD P00006 to add additional funds to strategic communication task area $489,875
Change Order P00005 · MOD P00005 to redefine and exercise OY1 $10,155,897
Change Order P00004 · MOD P00004 to exercise ESG-NG line items and add fund to strategic communication task $348,850
Funding Only Action P00003 · MOD to add funds to support o & m task $360,756
Supplemental Agreement for work within scope P00002 · Bilateral MOD to add ESG-NG tasks and additional funds for strategic communication and make COR change $1,087,371
Supplemental Agreement for work within scope P00001 · Bilateral MOD to add two more items onto DME support list $389,987
Original award $7,685,348

About this award

The Food and Drug Administration (FDA) awarded a contract to ICF Incorporated, L.L.C. on September 20, 2023, for the renewal of Operations & Maintenance (O&M), Durable Medical Equipment (DME), and advisory support services, with an exercise transition-out option. This $20.9 million Blanket Purchase Agreement (BPA) call is labor-hour priced and represents a continuation of technical and operational support services for the agency. The contract is performance-based through September 29, 2025, with work performed at ICF's Herndon, Virginia location. This award was not set aside for small businesses and was made under the General Services Administration's Multiple Award Schedule (MAS) vehicle, enabling the FDA to quickly access ICF's established consulting capabilities.

ICF Incorporated is a global consulting and technology services firm headquartered in Reston, Virginia, with extensive experience delivering advisory, implementation, and program management services to federal agencies since 2002. The company maintains substantial Indefinite Delivery Vehicle contracts across multiple federal agencies, including significant Blanket Purchase Agreements with the Environmental Protection Agency and Centers for Disease Control and Prevention. Through this FDA award, ICF will provide comprehensive support for facility operations, medical equipment management, and strategic advisory services, leveraging its demonstrated expertise in delivering complex government support services across diverse federal domains.

Quick answers

Who was awarded contract 75F40123F19012?

75F40123F19012 was awarded to ICF Incorporated, L.L.C. by Food and Drug Administration (Department of Health and Human Services) on September 20, 2023.

How much is contract 75F40123F19012 worth?

The government has obligated $20,337,833 on 75F40123F19012. Its potential value, with all options, is $20,920,984.

Is contract 75F40123F19012 an order under another contract?

Yes. 75F40123F19012 is a BPA call under GS35F328DA-75F40120A00042, a blanket purchase agreement, on Multiple Award Schedule (MAS).

Was contract 75F40123F19012 competed?

The extent of competition for 75F40123F19012 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award